Results 21 to 30 of about 216,445 (311)

Aspirin resistance in patients with acute coronary syndrome. Part 2

Кардиоваскулярная терапия и профилактика, 2011
Aim. In patients with acute coronary syndrome (ACS), to investigate the prevalence of aspirin resistance, its clinical features, prognostic effects, and potential correction. Material and methods.
N. S. Frolova, R. M. Shakhnovich, E. M. Kaznacheeva, O. V. Sirotkina, A. B. Dobrovolskyi   +4 more
doaj   +1 more source

The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study

BMC Cancer, 2021
Background Studies have indicated that individuals taking aspirin have a reduced risk of cancers and have also established chemo-preventive benefit of aspirin in colorectal cancer. However, research on the association between aspirin use and the survival
Min-Chun Chuang, Yao-Hsu Yang, Meng-Jer Hsieh, Yu-Ching Lin, Tsung-Ming Yang, Pau-Chung Chen, Ming-Szu Hung   +6 more
doaj   +1 more source

'Aspirin resistance' or treatment non-compliance: Which is to blame for cardiovascular complications?

Journal of Translational Medicine, 2008
Aspirin is one of the 'cornerstone' drugs in our current management of cardiovascular disorders. However, despite the prescription of aspirin recurrent vascular events still occur in 10–20% of patients.
Shantsila Eduard, Lip Gregory YH
doaj   +1 more source

Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia

Stroke Research and Treatment, 2021
Objective. To evaluate the aspirin resistance prevalence in patients with previous ischemic cerebrovascular disease undergoing aspirin therapy for secondary prevention. Materials and Methods.
Alejandro Roman-Gonzalez, Carlos Andrés Naranjo, Walter D. Cardona-Maya, Dionis Vallejo, Francisco Garcia, Cesar Franco, Leonor Alvarez, Luis Ignacio Tobón, Marta Ibeth López, Carolina Rua, Gabriel Bedoya, Ángela Cadavid, José Domingo Torres   +12 more
doaj   +1 more source

Contextualizing National Policies Regulating Access to Low‐Dose Aspirin in America and Europe Using the Full Report of a Transatlantic Patient Survey of Aspirin in Preventive Cardiology

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Aspirin is widely administered to prevent cardiovascular disease (CVD). However, appropriate use of aspirin depends on patient understanding of its risks, benefits, and indications, especially where aspirin is available over the counter (OTC).
Alan P. Jacobsen, Zi Lun Lim, Blair Chang, Kaleb D. Lambeth, Thomas M. Das, Colin Gorry, Michael McCague, Faisal Sharif, Darren Mylotte, William Wijns, Patrick W. J .C. Serruys, Roger S. Blumenthal, Seth S. Martin, John W. McEvoy   +13 more
doaj   +1 more source

Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs

Frontiers in Veterinary Science, 2019
Glucocorticoid administration is a risk factor for thromboembolism in hypercoagulable dogs, and it is unknown if aspirin counteracts glucocorticoid-induced hypercoagulability. The objective was to determine the effects of sustained aspirin and prednisone
John M. Thomason, Allison P. Mooney, Joshua M. Price, Jacqueline C. Whittemore   +3 more
doaj   +1 more source

Preoperative aspirin use and acute kidney injury after cardiac surgery: A propensity-score matched observational study. [PDF]

PLoS ONE, 2017
BACKGROUND:The association between preoperative aspirin use and postoperative acute kidney injury (AKI) in cardiovascular surgery is unclear. We sought to evaluate the effect of preoperative aspirin use on postoperative AKI in cardiac surgery.
Min Hur, Chang-Hoon Koo, Hyung-Chul Lee, Sun-Kyung Park, Minkyung Kim, Won Ho Kim, Jin-Tae Kim, Jae-Hyon Bahk   +7 more
doaj   +1 more source

286 Genetic, laboratory and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia

Journal of Clinical and Translational Science, 2023
OBJECTIVES/GOALS: Low-dose aspirin is an established treatment to prevent preeclampsia, a leading cause of maternal and perinatal complications. Nevertheless, aspirin failure is not uncommon.
Amihai Rottenstreich, Roger Vaughan, Barry S Coller   +2 more
doaj   +1 more source

Aspirin: yesterday, today, and tomorrow

Pediatria i Medycyna Rodzinna, 2014
Clinical utility of aspirin (acetylsalicylic acid, ASA) is one of the more important issues in the primary and secondary prevention of cardiovascular disease.
Marina Nikołajewna Dołżenko
doaj   +1 more source

Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study. [PDF]

PLoS ONE, 2016
BACKGROUND:Low-dose aspirin is widely recommended for patients at high risk for cardiovascular disease (CVD); however, it remains uncertain whether long-term treatment adversely affects renal function in patients with diabetes.
Sadanori Okada, Takeshi Morimoto, Hisao Ogawa, Mio Sakuma, Hirofumi Soejima, Masafumi Nakayama, Hideaki Jinnouchi, Masako Waki, Yasuhiro Akai, Hitoshi Ishii, Yoshihiko Saito, Investigators for the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes trial   +11 more
doaj   +1 more source